Kidney Tumor Program

  • Meet the Team

    The Kidney Tumor Program, part of the Cancer and Blood Diseases Institute, is home to specialists with a wide variety of backgrounds and areas of focus. As a team, this diversity makes us better prepared to care for your child’s unique needs.
  • Show All

    Medical Director

    A photo of James Geller.

    James I. Geller, MD
    Medical Director, Kidney and Liver Tumors Program

    513-636-4266

    james.geller@cchmc.org

    James I. Geller, MD

    Medical Director, Kidney and Liver Tumors Program

    Co-Medical Director, Retinoblastoma Program

    Associate Director, Global Cancer Programs

    Associate Professor, UC Department of Pediatrics

    Phone: 513-636-4266

    Fax: 513-636-3549

    Email: james.geller@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Developmental therapeutics; renal / liver / retinoblastoma / neuro-oncology

    Research Interests

    Elucidating ways to translate the use of biological response modifiers in combination with conventional chemotherapeutics

    Biography

    James I. Geller, MD, completed his undergraduate training at Dartmouth College, graduate medical training at the Sackler School of Medicine, residency training in pediatrics at New York Medical College and pediatric hematology / oncology training at St. Jude Children's Research Hospital. His current appointment is with the University of Cincinnati and Children's Hospital Medical Center in the capacity of associate professor of pediatrics.

    Dr. Geller's clinical and academic interests pertain to children and families affected by solid tumors, including brain tumors. Dr. Geller's expertise is recognized both nationally and internationally in the fields of retinoblastoma, renal tumors, liver tumors and brain tumors, as witnessed by his appointments to the Children's Oncology Group (COG) Rare/Retinoblastoma Committee as both a Steering/Voting Member and as liaison to the COG Young Investigator Committee; the COG Renal Tumor Committee (RTC) as Steering/Voting Member, RTC Sub-Committee Chair of Developmental Therapeutics, and RTC liaison to both the COG Developmental Therapeutics Committee and the Pediatric Preclinical Testing Program Guidance Committee; and to the Central Nervous System (Brain Tumor) Committee as a voting member. Dr. Geller has been an invited speaker at numerous national and international meetings and symposia and spearheads both local and national clinical research initiatives in these areas, with an emphasis on finding new treatment options.

    Education and Training

    MD: Sackler School of Medicine, 1997.

    Residency: New York Medical College, 2000.

    Fellowship: St Jude Children's Research Hospital, 2004.

    Certification: Pediatrics, 2000, 2007; Pediatric Hematology / Oncology, 2005.

    Publications

    View PubMed Publications

    Oncologists

    A photo of Rajaram Nagarajan, MD.

    Rajaram Nagarajan, MD, MS
    Associate Director, Oncology Clinical Operations

    513-636-0670

    rajaram.nagarajan@cchmc.org

    Rajaram Nagarajan, MD, MS

    Associate Director, Oncology Clinical Operations

    Associate Professor, UC Department of Pediatrics

    Phone: 513-636-0670

    Fax: 513-636-3549

    Email: rajaram.nagarajan@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Bone tumors; late effects of pediatric cancer therapy

    Research Interests

    Outcomes following cancer therapy and bone sarcomas

    Education and Training

    BA: Pre-Medical Sciences, Lehigh University, Bethlehem, PA, 1991.

    MD: Medical College of Pennsylvania, Philadelphia, PA, 1995.

    Internship and Residency: Pediatrics, Medical College of Virginia, Richmond, VA, 1998.

    Fellowship Training: Hematology / Oncology / BMT, University of Minnesota, Minneapolis, MN, 2002.

    MS: Clinical Research, University of Minnesota, Minneapolis, MN, 2002.

    Certifications: Pediatrics, Pediatric Hematology / Oncology.

    Publications

    View PubMed Publications
    A photo of Brian Weiss.

    Brian D. Weiss, MD
    Associate Director for Safety and Compliance, Cancer and Blood Diseases Institute

    513-636-9863

    brian.weiss@cchmc.org

    Brian D. Weiss, MD

    Associate Director for Safety and Compliance, Cancer and Blood Diseases Institute

    Cincinnati Children's Principal Investigator, New Approaches to Neuroblastoma Therapy Consortium

    Medical Director, Neuroblastoma Program

    Associate Professor, UC Department of Pediatrics

    Phone: 513-636-9863

    Fax: 513-636-3549

    Email: brian.weiss@cchmc.org

    Show All

    Specialties

    Targeted agents for neurofibromatosis type 1-related malignancies; high-risk neuroblastoma and 131I-MIBG treatment of neuroblastoma; new approaches to targeting and killing neuroblastoma cells

    Education and Training

    MD: Northwestern University Medical School, Chicago, IL, 1993.

    Residency and Chief Residency: Pediatrics, University of California, San Francisco, CA, 1993-1997.

    Fellowship: Pediatric Hematology/Oncology, University of California, San Francisco, CA, 1997-2000.

    Certification: National Medical Board; Pediatrics;1996, 2002; Pediatric Hematology-Oncology, 2000, 2007

    Publications

    View PubMed Publications

    Grants

    Children's Oncology Group Chairs Grant. National Institutes of Health (Children's Oncology Group)
    U10 CA 098543 Mar 2011 - Feb 2012.